Question 1

What is the catalog number for GSK583, RIP2 kinase inhibitor?

Accepted Answer

The catalog number for GSK583, RIP2 kinase inhibitor is TBI4761-50MG.

Question 2

What sizes are available for GSK583, RIP2 kinase inhibitor?

Accepted Answer

GSK583, RIP2 kinase inhibitor is available in the following size(s): 50 mg.

Question 3

Is GSK583, RIP2 kinase inhibitor in stock?

Accepted Answer

GSK583, RIP2 kinase inhibitor is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

GSK583, RIP2 kinase inhibitor

Product Specifications

Shipping Conditions

Frequently Asked Questions

Explore Other Products

MART-1 / Melan-A (MLANA/788), CF640R conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF568 conjugate, 0.1mg/mL

Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/3557), CF640R conjugate, 0.1mg/mL

NRF1 (NRF1/2609), CF488A conjugate, 0.1mg/mL

EGFRvIII (Epidermal Growth Factor Receptor, Variant III) (GFR/2600R), CF594 conjugate, 0.1mg/mL

PAX5 / BSAP (Early B-Cell Marker) (PAX5/2595), CF405S conjugate, 0.1mg/mL